CantorEquity CEPT Declines 181 Amid Market Weakness 20260515 UWM UWMC Stock Today Drops 099 Key Support at 285 20260515 RBIs Recent Rate Cut Diluted Its Policy Framework Says Nomura Google and Blackstone Join Forces to Launch AI Cloud Venture with Custom Chips Ondas DefenseAI Ambition A Strategic Leap into Autonomous Systems Vestas Wind Systems Shares Decline After Company Warns Margins at Low End of Guidance Singtel Shares Slide 64 as Singapore Operations Weigh on FullYear Results Vanguard Dividend Appreciation ETF vs Fidelity High Dividend ETF Weighing Yield Fees and Performance Rising Gas Prices Disproportionately Impact LowIncome Households New York Fed Study Indicates Charter Communications Revises Buyout Offer for Liberty Broadband Under Improved Terms FRSX Q3 2021 Earnings NarrowerthanExpected Loss Surprises Market BRFH Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction GLUE Q1 2026 Earnings WiderThanExpected Loss as PreClinical Biotech Advances Pipeline ZION Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Omitted CPRT Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Lower Neuphoria Therapeutics NEUP Surges 7 as Shares Test Key Resistance LeMaitre Vascular LMAT Drops 3 as Shares Test Key Support Zone Heartbeam Inc Warrant BEATW Holds Flat at 009 Amid Low Volume and Uncertain Catalysts Jack In The Box JACK Edges Higher as Stock Tests Key Resistance Level Interparfums IPAR Rallies 263 as Fragrance Sector Momentum Builds Remitly Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies CDP Q1 2026 Earnings EPS Surpasses Estimates with 2 Beat Diversified Energy Company Q2 2024 Earnings Strong EPS Beat Despite Negative Market Reaction SIMO Q1 2026 Earnings Strong EPS Beat Drives Share Price Higher BRFH Q1 2026 Earnings EPS Surprise Beat Drives Stock Higher Amid Revenue Disclosures Uncertainty ITT Inc Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Bitcoin Dips Below 76000 Poised for Weekly Decline Amid Liquidations and Rate Volatility HPP Q1 2026 Earnings Loss Narrows on Surprise Beat but Stock Declines Phathom Pharmaceuticals PHAT Slips 216 as Stock Tests Key Support Levels